Harness the power of Premium Cold Plasma to penetrate biofilm, destroy resistant bacteria,1 and accelerate healing.2,3
Chronic infections don’t stand still, they escalate
Healing
is delayed
Infections resist standard treatments and protocols,4,6 slowing patients’ recovery.
Escalation risk increases
Likelihood of further complications, revisional surgery or device removal increases.7,8
Recovery
is prolonged
Patients face repeated appointments, and extended hospital stays as infections persist.9
Break the cycle of infection
Manage infections with confidence with Premium Cold Plasma, proven to destroy resistant bacteria1 where other therapies fail.
01/
Destroy infection
Tackles biofilm and destroys resistant bacteria1 where standard treatment options fail.
02/
Accelerate healing2,3
Clinically proven to reduce bacterial load by 73.5%1 and deliver up to 100% reduction in wound size and depth.10
03/
Restore recovery
Safe, non-contact therapy with 18+ years of clinical use and no reported adverse events.11
18+ years of clinical experience • 10,000+ treatments worldwide • 85+ peer-reviewed studies •
18+ years of clinical experience • 10,000+ treatments worldwide • 85+ peer-reviewed studies •
18+ years of clinical experience • 10,000+ treatments worldwide • 85+ peer-reviewed studies •
18+ years of clinical experience • 10,000+ treatments worldwide • 85+ peer-reviewed studies •
18+ years of clinical experience • 10,000+ treatments worldwide • 85+ peer-reviewed studies •
clears infection at the source
SteriPlas uses Premium Cold Plasma to penetrate biofilms, destroy resistant bacteria,1 and accelerate healing2,3 more effectively than standard therapies.
Reduces bacterial load by 73.5%1
Decreases would size and depth by up to 100%10
Consistently outperforms antibiotics1
Discover SteriPlas
Getting started is simple
01
Speak to a representative to check eligibility
Meet with our team and check if you’re eligible to evaluate.
02
Start a fully supported evaluation
Get full training, clinical support, and outcome tracking throughout.
03
Choose to lease or buy
Decide on the best funding route for your hospital.
References
1. Isbary G, Heinlin J, Shimizu T, et al. Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol. 2012;167(2):404-410. doi:10.1111/j.1365-2133.2012.10923.x
2. Heinlin J, Zimmermann JL, Zeman F, et al. Randomized placebo-controlled human pilot study of cold atmospheric argon plasma on skin graft donor sites. Wound Repair Regen Off Publ Wound Heal Soc Eur Tissue Repair Soc. 2013;21(6):800-807. doi:10.1111/wrr.12078
3. Isbary G, Stolz W, Shimizu T, et al. Cold atmospheric argon plasma treatment may accelerate wound healing in chronic wounds: Results of an open retrospective randomized controlled study in vivo. Clin Plasma Med. 2013;1(2):25-30. doi:10.1016/j.cpme.2013.06.001
4. Stuermer EK, Plattfaut I, Dietrich M, et al. In vitro Activity of Antimicrobial Wound Dressings on P. aeruginosa Wound Biofilm. Front Microbiol. 2021;12. doi:10.3389/fmicb.2021.664030
5. Jager NGL, van Hest RM, Lipman J, Roberts JA, Cotta MO. Antibiotic exposure at the site of infection: principles and assessment of tissue penetration. Expert Rev Clin Pharmacol. 2019;12(7):623-634. doi:10.1080/17512433.2019.1621161
6. Zhao A, Sun J, Liu Y. Understanding bacterial biofilms: From definition to treatment strategies. Front Cell Infect Microbiol. 2023;13:1137947. doi:10.3389/fcimb.2023.1137947
7. Patel CB, Blue L, Cagliostro B, et al. Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial. J Heart Lung Transplant. 2020;39(8):774-781. doi:10.1016/j.healun.2020.03.002
8. Taghavi S, D T, A.G D, M.F M, K.R B, A I. Surgical Management of Driveline Infection in Continuous Flow Left Ventricular Assist Devices – The Journal of Heart and Lung Transplantation. 2016. Accessed September 22, 2025. https://www.jhltonline.org/article/S1053-2498(16)00393-4/fulltext
9. Wolny D, Štěpánek L, Horáková D, Thomas J, Zapletalová J, Patel MS. Risk Factors for Non-Healing Wounds—A Single-Centre Study. J Clin Med. 2024;13(4):1003. doi:10.3390/jcm13041003
10. Moelleken M, Jockenhöfer F, Wiegand C, Buer J, Benson S, Dissemond J. Pilot study on the influence of cold atmospheric plasma on bacterial contamination and healing tendency of chronic wounds. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2020;18(10):1094-1101. doi:10.1111/ddg.14294
11. Data on file.